Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SFRI is a French in vitro diagnostics company that develops, manufactures, and sells diagnostic instruments and reagents for routine clinical laboratory testing. Founded in 1977, the company focuses primarily on hematology, biochemistry, and immunology workflows, with products including hematology analyzers, biochemistry analyzers, immunology equipment, and associated reagents, controls, and calibrators. SFRI operates as a commercial-stage diagnostics manufacturer rather than a therapeutic drug developer, and its business is centered on supplying clinical laboratories and distributors internationally. The company emphasizes ISO 13485-certified quality systems, CE-marked products, and broad export reach across more than 100 countries. SFRI is also described as part of the NEOVITEA international group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SFRI.